icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Mon 19 Oct 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

News

asd
icon 2026-06-17

SFDA CEO Explores Global Best Practices in Advanced Therapies During Medical and Research Centers Vi

The CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham S. Aljadhey, conducted a series of site visits to specialized medical and research...
More
sfg
icon 2026-06-15

SFDA Opens Submissions for the 6th Annual Regulatory Research Day 2026

The Saudi Food and Drug Authority (SFDA) has officially announced the opening of submissions for its sixth annual Regulatory Research Day 2026. The...
More
dfsd
icon 2026-06-11

SFDA Achieves a Middle East First as Dammam Reference Laboratory Earns Accreditation for PFAS Monito

The Saudi Food and Drug Authority (SFDA) has achieved a significant scientific and regulatory milestone by securing ISO/IEC 17025 accreditation for...
More
scdaa
icon 2026-06-05

SFDA:AI-Powered 'RASID'Service Cuts Controlled Medication Verification Time for Hajj Pilgrims by 98%

The Saudi Food and Drug Authority (SFDA) has activated the Regulatory AI System for Incoming Drugs (RASID) service to support regulatory operations at...
More
4
icon 2026-06-07

SFDA Grants Orphan Drug Designation to “Gomekli” for the Treatment of Neurofibromatosis Type 1 (NF1)

The Saudi Food and Drug Authority (SFDA) has granted orphan drug designation to Gomekli (mirdametinib), developed by SpringWorks Therapeutics, to...
More
4
icon 2026-06-04

The SFDA Grants Breakthrough Designation to "ZENBEXUS" for the Treatment of Adult Patients with Mult

The Saudi Food and Drug Authority (SFDA) has granted Breakthrough Designation to ZENBEXUS (Iberdomide), developed by Bristol-Myers Squibb, for the...
More